The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus reportFederica Miglietta, Grazia Arpino, Giuseppe Curigliano et al.|Critical Reviews in Oncology/Hematology|2025Cited by 4